NDUFB4P9

Across TCGA pan-cancer cohorts, NDUFB4P9 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated NDUFB4P9 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher NDUFB4P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFB4P9 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.

UCS, HNSC, and THCA are the cancer types where NDUFB4P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.102	0.591	<.001	72	view →
HNSC	OS	Tertile	III,IV	0.746	0.303	.011	63	view →
THCA	OS	Tertile	All	0.731	0.959	<.001	45	view →
ACC	DFS	Tertile	II,III,IV	0.057	0.581	.003	45	view →
ESCA	DFS	Tertile	All	0.350	0.560	.005	36	view →
PAAD	OS	Tertile	II,III,IV	0.037	0.621	<.001	18	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
CESC	DFS	Tertile	II,III,IV	1.000	0.444	.037	12	view →
OV	DFS	Tertile	III,IV	0.648	0.518	.017	12	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →
LIHC	OS	Tertile	II,III,IV	0.248	0.715	.042	9	view →
UCEC	DFS	Tertile	II,III,IV	0.681	0.828	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

NDUFB4P9–UCS (OS)

Open the UCS breakdown →